World Dense Breast Day emphasizes the need for awareness and advocacy for individuals with dense breasts, which can ...

New research highlights increased stroke, heart attack, and heart failure risks in cancer survivors, especially those treated ...

Demonstration projects to show accurate use of artificial intelligence (AI) in cancer care are important to prevent a loss of ...

"As CMMI continues to test new equity adjustments, it is important that changes be grounded in scientific principles with ...

Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

Patients with sickle cell anemia (SCA) and persistent albuminuria (PA) exhibited significantly higher levels of urinary ...

A new study demonstrates that the combination of lenalidomide (Revlimid) and obinutuzumab (Gazyva) is effective and ...

Joseph Alvarnas, MD, of City of Hope, discusses how he envisions the future of cancer care over the next decade.

Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...

Armstrong, MD, MPH, chief of dermatology, UCLA, discusses clinical trial findings from the phase 2b study on zasocitinib.

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

A recent analysis investigated the state of metabolic disruption experienced by patients with spinal muscular atrophy (SMA), ...